1. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; Canadian Cardiovascular Society (2004) ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 110: e82?292
2. Antman EM, Cohen M, McCabe C, Goodman SG, Murphy SA, Braunwald E (2002) Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE. Eur Heart J 23: 308?314
3. Bertrand ME, Simoons ML, Fox KAA (2002) Management of acute coronary syndromes in patients presenting without persistent ST segment elevation. Eur Heart J 23: 1809?1840
4. Bertrand ME, Simoons ML, Fox KA, Wallentin LC, Hamm CW, McFadden E, De Feyter PJ, Specchia G, Ruzyllo W; Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology (2002) Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 23 (23):1809?1840. Erratum in: Eur Heart J 24: 1174?1175
5. Boersma E, Maas ACP, Deckers JW et al. (1996) Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 348: 771?775